Improving community participation to eliminate lymphatic filariasis in American Samoa.
Identifieur interne : 002874 ( PubMed/Curation ); précédent : 002873; suivant : 002875Improving community participation to eliminate lymphatic filariasis in American Samoa.
Auteurs : Jonathan D. King [États-Unis] ; Emily Zielinski-Gutierrez ; Molisamoa Pa'Au ; Patrick LammieSource :
- Acta tropica [ 1873-6254 ] ; 2011.
Descripteurs français
- KwdFr :
- Albendazole (administration et posologie), Albendazole (usage thérapeutique), Animaux, Antihelminthiques (administration et posologie), Antihelminthiques (usage thérapeutique), Association de médicaments, Calendrier d'administration des médicaments, Caractéristiques familiales, Connaissances, attitudes et pratiques en santé, Diéthylcarbamazine (administration et posologie), Diéthylcarbamazine (usage thérapeutique), Enquêtes et questionnaires, Filaricides (administration et posologie), Filaricides (usage thérapeutique), Filariose lymphatique (traitement médicamenteux), Filariose lymphatique (épidémiologie), Humains, Participation communautaire, Prévalence, Samoa américaines (épidémiologie), Surveillance sentinelle, Wuchereria bancrofti (), Évaluation de programme.
- MESH :
- administration et posologie : Albendazole, Antihelminthiques, Diéthylcarbamazine, Filaricides.
- traitement médicamenteux : Filariose lymphatique.
- usage thérapeutique : Albendazole, Antihelminthiques, Diéthylcarbamazine, Filaricides.
- épidémiologie : Filariose lymphatique, Samoa américaines.
- Animaux, Association de médicaments, Calendrier d'administration des médicaments, Caractéristiques familiales, Connaissances, attitudes et pratiques en santé, Enquêtes et questionnaires, Humains, Participation communautaire, Prévalence, Surveillance sentinelle, Wuchereria bancrofti, Évaluation de programme.
English descriptors
- KwdEn :
- Albendazole (administration & dosage), Albendazole (therapeutic use), American Samoa (epidemiology), Animals, Anthelmintics (administration & dosage), Anthelmintics (therapeutic use), Community Participation, Diethylcarbamazine (administration & dosage), Diethylcarbamazine (therapeutic use), Drug Administration Schedule, Drug Therapy, Combination, Elephantiasis, Filarial (drug therapy), Elephantiasis, Filarial (epidemiology), Family Characteristics, Filaricides (administration & dosage), Filaricides (therapeutic use), Health Knowledge, Attitudes, Practice, Humans, Prevalence, Program Evaluation, Sentinel Surveillance, Surveys and Questionnaires, Wuchereria bancrofti (drug effects).
- MESH :
- chemical , administration & dosage : Albendazole, Anthelmintics, Diethylcarbamazine, Filaricides.
- chemical , therapeutic use : Albendazole, Anthelmintics, Diethylcarbamazine, Filaricides.
- drug effects : Wuchereria bancrofti.
- drug therapy : Elephantiasis, Filarial.
- epidemiology : American Samoa, Elephantiasis, Filarial.
- Animals, Community Participation, Drug Administration Schedule, Drug Therapy, Combination, Family Characteristics, Health Knowledge, Attitudes, Practice, Humans, Prevalence, Program Evaluation, Sentinel Surveillance, Surveys and Questionnaires.
Abstract
In 2000, the American Samoa Department of Health initiated a campaign of annual mass drug administration (MDA) with albendazole and diethylcarbamazine (DEC) to eliminate transmission of filariasis. Drug coverage was well below prescribed targets in the first three campaigns, ranging from 24 to 52% of the total population. Evaluation findings from a variety of formative research methods identified opportunities to improve MDA coverage and ensuing program modifications resulted in increased drug coverage of 65-71% in the following four annual distributions. Partnering with churches for drug distribution and using multiple media channels for health promotion led to sustained program improvements. With the increased emphasis on the use of mass distribution for delivery of drugs for a number of neglected tropical diseases, other programs may benefit from a similar approach.
DOI: 10.1016/j.actatropica.2010.08.021
PubMed: 20932818
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :002874
Links to Exploration step
pubmed:20932818Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Improving community participation to eliminate lymphatic filariasis in American Samoa.</title><author><name sortKey="King, Jonathan D" sort="King, Jonathan D" uniqKey="King J" first="Jonathan D" last="King">Jonathan D. King</name><affiliation wicri:level="1"><nlm:affiliation>Division of Parasitic Diseases, Centers for Disease Control and Prevention, 4770 Buford Highway, Atlanta, GA 30341, United States. jonathan.king@emory.edu</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Division of Parasitic Diseases, Centers for Disease Control and Prevention, 4770 Buford Highway, Atlanta, GA 30341</wicri:regionArea></affiliation></author><author><name sortKey="Zielinski Gutierrez, Emily" sort="Zielinski Gutierrez, Emily" uniqKey="Zielinski Gutierrez E" first="Emily" last="Zielinski-Gutierrez">Emily Zielinski-Gutierrez</name></author><author><name sortKey="Pa Au, Molisamoa" sort="Pa Au, Molisamoa" uniqKey="Pa Au M" first="Molisamoa" last="Pa'Au">Molisamoa Pa'Au</name></author><author><name sortKey="Lammie, Patrick" sort="Lammie, Patrick" uniqKey="Lammie P" first="Patrick" last="Lammie">Patrick Lammie</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2011">2011</date><idno type="RBID">pubmed:20932818</idno><idno type="pmid">20932818</idno><idno type="doi">10.1016/j.actatropica.2010.08.021</idno><idno type="wicri:Area/PubMed/Corpus">002874</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">002874</idno><idno type="wicri:Area/PubMed/Curation">002874</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">002874</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Improving community participation to eliminate lymphatic filariasis in American Samoa.</title><author><name sortKey="King, Jonathan D" sort="King, Jonathan D" uniqKey="King J" first="Jonathan D" last="King">Jonathan D. King</name><affiliation wicri:level="1"><nlm:affiliation>Division of Parasitic Diseases, Centers for Disease Control and Prevention, 4770 Buford Highway, Atlanta, GA 30341, United States. jonathan.king@emory.edu</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Division of Parasitic Diseases, Centers for Disease Control and Prevention, 4770 Buford Highway, Atlanta, GA 30341</wicri:regionArea></affiliation></author><author><name sortKey="Zielinski Gutierrez, Emily" sort="Zielinski Gutierrez, Emily" uniqKey="Zielinski Gutierrez E" first="Emily" last="Zielinski-Gutierrez">Emily Zielinski-Gutierrez</name></author><author><name sortKey="Pa Au, Molisamoa" sort="Pa Au, Molisamoa" uniqKey="Pa Au M" first="Molisamoa" last="Pa'Au">Molisamoa Pa'Au</name></author><author><name sortKey="Lammie, Patrick" sort="Lammie, Patrick" uniqKey="Lammie P" first="Patrick" last="Lammie">Patrick Lammie</name></author></analytic><series><title level="j">Acta tropica</title><idno type="eISSN">1873-6254</idno><imprint><date when="2011" type="published">2011</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Albendazole (administration & dosage)</term><term>Albendazole (therapeutic use)</term><term>American Samoa (epidemiology)</term><term>Animals</term><term>Anthelmintics (administration & dosage)</term><term>Anthelmintics (therapeutic use)</term><term>Community Participation</term><term>Diethylcarbamazine (administration & dosage)</term><term>Diethylcarbamazine (therapeutic use)</term><term>Drug Administration Schedule</term><term>Drug Therapy, Combination</term><term>Elephantiasis, Filarial (drug therapy)</term><term>Elephantiasis, Filarial (epidemiology)</term><term>Family Characteristics</term><term>Filaricides (administration & dosage)</term><term>Filaricides (therapeutic use)</term><term>Health Knowledge, Attitudes, Practice</term><term>Humans</term><term>Prevalence</term><term>Program Evaluation</term><term>Sentinel Surveillance</term><term>Surveys and Questionnaires</term><term>Wuchereria bancrofti (drug effects)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Albendazole (administration et posologie)</term><term>Albendazole (usage thérapeutique)</term><term>Animaux</term><term>Antihelminthiques (administration et posologie)</term><term>Antihelminthiques (usage thérapeutique)</term><term>Association de médicaments</term><term>Calendrier d'administration des médicaments</term><term>Caractéristiques familiales</term><term>Connaissances, attitudes et pratiques en santé</term><term>Diéthylcarbamazine (administration et posologie)</term><term>Diéthylcarbamazine (usage thérapeutique)</term><term>Enquêtes et questionnaires</term><term>Filaricides (administration et posologie)</term><term>Filaricides (usage thérapeutique)</term><term>Filariose lymphatique (traitement médicamenteux)</term><term>Filariose lymphatique (épidémiologie)</term><term>Humains</term><term>Participation communautaire</term><term>Prévalence</term><term>Samoa américaines (épidémiologie)</term><term>Surveillance sentinelle</term><term>Wuchereria bancrofti ()</term><term>Évaluation de programme</term></keywords><keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Albendazole</term><term>Anthelmintics</term><term>Diethylcarbamazine</term><term>Filaricides</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Albendazole</term><term>Anthelmintics</term><term>Diethylcarbamazine</term><term>Filaricides</term></keywords><keywords scheme="MESH" qualifier="administration et posologie" xml:lang="fr"><term>Albendazole</term><term>Antihelminthiques</term><term>Diéthylcarbamazine</term><term>Filaricides</term></keywords><keywords scheme="MESH" qualifier="drug effects" xml:lang="en"><term>Wuchereria bancrofti</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Elephantiasis, Filarial</term></keywords><keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>American Samoa</term><term>Elephantiasis, Filarial</term></keywords><keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Filariose lymphatique</term></keywords><keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Albendazole</term><term>Antihelminthiques</term><term>Diéthylcarbamazine</term><term>Filaricides</term></keywords><keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Filariose lymphatique</term><term>Samoa américaines</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Animals</term><term>Community Participation</term><term>Drug Administration Schedule</term><term>Drug Therapy, Combination</term><term>Family Characteristics</term><term>Health Knowledge, Attitudes, Practice</term><term>Humans</term><term>Prevalence</term><term>Program Evaluation</term><term>Sentinel Surveillance</term><term>Surveys and Questionnaires</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Animaux</term><term>Association de médicaments</term><term>Calendrier d'administration des médicaments</term><term>Caractéristiques familiales</term><term>Connaissances, attitudes et pratiques en santé</term><term>Enquêtes et questionnaires</term><term>Humains</term><term>Participation communautaire</term><term>Prévalence</term><term>Surveillance sentinelle</term><term>Wuchereria bancrofti</term><term>Évaluation de programme</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">In 2000, the American Samoa Department of Health initiated a campaign of annual mass drug administration (MDA) with albendazole and diethylcarbamazine (DEC) to eliminate transmission of filariasis. Drug coverage was well below prescribed targets in the first three campaigns, ranging from 24 to 52% of the total population. Evaluation findings from a variety of formative research methods identified opportunities to improve MDA coverage and ensuing program modifications resulted in increased drug coverage of 65-71% in the following four annual distributions. Partnering with churches for drug distribution and using multiple media channels for health promotion led to sustained program improvements. With the increased emphasis on the use of mass distribution for delivery of drugs for a number of neglected tropical diseases, other programs may benefit from a similar approach.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">20932818</PMID><DateCreated><Year>2011</Year><Month>10</Month><Day>11</Day></DateCreated><DateCompleted><Year>2012</Year><Month>01</Month><Day>23</Day></DateCompleted><DateRevised><Year>2016</Year><Month>11</Month><Day>25</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1873-6254</ISSN><JournalIssue CitedMedium="Internet"><Volume>120 Suppl 1</Volume><PubDate><Year>2011</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Acta tropica</Title><ISOAbbreviation>Acta Trop.</ISOAbbreviation></Journal><ArticleTitle>Improving community participation to eliminate lymphatic filariasis in American Samoa.</ArticleTitle><Pagination><MedlinePgn>S48-54</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.actatropica.2010.08.021</ELocationID><Abstract><AbstractText>In 2000, the American Samoa Department of Health initiated a campaign of annual mass drug administration (MDA) with albendazole and diethylcarbamazine (DEC) to eliminate transmission of filariasis. Drug coverage was well below prescribed targets in the first three campaigns, ranging from 24 to 52% of the total population. Evaluation findings from a variety of formative research methods identified opportunities to improve MDA coverage and ensuing program modifications resulted in increased drug coverage of 65-71% in the following four annual distributions. Partnering with churches for drug distribution and using multiple media channels for health promotion led to sustained program improvements. With the increased emphasis on the use of mass distribution for delivery of drugs for a number of neglected tropical diseases, other programs may benefit from a similar approach.</AbstractText><CopyrightInformation>Copyright © 2010 Elsevier B.V. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>King</LastName><ForeName>Jonathan D</ForeName><Initials>JD</Initials><AffiliationInfo><Affiliation>Division of Parasitic Diseases, Centers for Disease Control and Prevention, 4770 Buford Highway, Atlanta, GA 30341, United States. jonathan.king@emory.edu</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zielinski-Gutierrez</LastName><ForeName>Emily</ForeName><Initials>E</Initials></Author><Author ValidYN="Y"><LastName>Pa'au</LastName><ForeName>Molisamoa</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Lammie</LastName><ForeName>Patrick</ForeName><Initials>P</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D013486">Research Support, U.S. Gov't, Non-P.H.S.</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2010</Year><Month>10</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Acta Trop</MedlineTA><NlmUniqueID>0370374</NlmUniqueID><ISSNLinking>0001-706X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000871">Anthelmintics</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D005369">Filaricides</NameOfSubstance></Chemical><Chemical><RegistryNumber>F4216019LN</RegistryNumber><NameOfSubstance UI="D015766">Albendazole</NameOfSubstance></Chemical><Chemical><RegistryNumber>V867Q8X3ZD</RegistryNumber><NameOfSubstance UI="D004049">Diethylcarbamazine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D015766" MajorTopicYN="N">Albendazole</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration & dosage</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018948" MajorTopicYN="N">American Samoa</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000871" MajorTopicYN="N">Anthelmintics</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration & dosage</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003256" MajorTopicYN="Y">Community Participation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004049" MajorTopicYN="N">Diethylcarbamazine</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration & dosage</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004334" MajorTopicYN="N">Drug Administration Schedule</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004359" MajorTopicYN="N">Drug Therapy, Combination</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004605" MajorTopicYN="N">Elephantiasis, Filarial</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005191" MajorTopicYN="N">Family Characteristics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005369" MajorTopicYN="N">Filaricides</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration & dosage</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007722" MajorTopicYN="N">Health Knowledge, Attitudes, Practice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015995" MajorTopicYN="N">Prevalence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015397" MajorTopicYN="N">Program Evaluation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018571" MajorTopicYN="N">Sentinel Surveillance</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011795" MajorTopicYN="N">Surveys and Questionnaires</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014958" MajorTopicYN="N">Wuchereria bancrofti</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2009</Year><Month>09</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2010</Year><Month>05</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2010</Year><Month>08</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2010</Year><Month>10</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2010</Year><Month>10</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2012</Year><Month>1</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">20932818</ArticleId><ArticleId IdType="pii">S0001-706X(10)00241-X</ArticleId><ArticleId IdType="doi">10.1016/j.actatropica.2010.08.021</ArticleId></ArticleIdList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/PubMed/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002874 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd -nk 002874 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= LymphedemaV1
|flux= PubMed
|étape= Curation
|type= RBID
|clé= pubmed:20932818
|texte= Improving community participation to eliminate lymphatic filariasis in American Samoa.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/RBID.i -Sk "pubmed:20932818" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd \
| NlmPubMed2Wicri -a LymphedemaV1
| This area was generated with Dilib version V0.6.31. |  |